2024
Evaluation of combination vaccines targeting transmission of Plasmodium falciparum and P. vivax
Cao Y, Hayashi C, Araujo M, Tripathi A, Andrade A, Medeiros J, Vinetz J, Kumar N. Evaluation of combination vaccines targeting transmission of Plasmodium falciparum and P. vivax. Vaccine 2024, 126140. PMID: 39033079, DOI: 10.1016/j.vaccine.2024.07.041.Peer-Reviewed Original ResearchDirect membrane feeding assaysTransmission-reducing activityStandard membrane feeding assayMembrane feeding assaysP. vivaxDNA vaccineP. falciparumPlasmodium falciparumTransmission of Plasmodium falciparumAntibody responseDNA vaccine platformP. vivax accountsGlobal malaria burdenTransmission-blocking activityTransmission of malariaCombination of DNA vaccineIn vivo electroporationCombined DNA vaccineMalaria burdenMalaria transmissionTransmission-blockingAssess immunogenicityVaccine platformClinical studiesCombination group
2021
Heterogeneity in response to serological exposure markers of recent Plasmodium vivax infections in contrasting epidemiological contexts
Rosado J, White MT, Longley RJ, Lacerda M, Monteiro W, Brewster J, Sattabongkot J, Guzman-Guzman M, Llanos-Cuentas A, Vinetz JM, Gamboa D, Mueller I. Heterogeneity in response to serological exposure markers of recent Plasmodium vivax infections in contrasting epidemiological contexts. PLOS Neglected Tropical Diseases 2021, 15: e0009165. PMID: 33591976, PMCID: PMC7909627, DOI: 10.1371/journal.pntd.0009165.Peer-Reviewed Original ResearchConceptsSerological exposure markersBlood-stage infectionLow transmission settingsP. vivax infectionPlasmodium vivax infectionHigh transmission settingsVivax infectionTransmission settingsAntibody titersAntibody responseExposure markersDifferent transmission intensitiesIgG responsesSerological markersPrevious infectionReceiver Operating Characteristic (ROC) analysisEndemic settingsMalaria eliminationPeruvian cohortOperating characteristics analysisP. vivaxMalaria controlRecent exposureInfectionEpidemiological context